FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and concerns a solid dosage form containing azithromycin dihydrate as an active substance in the amount of 83.2-93.2% and pharmaceutically acceptable target additives. A tablet core is film-coated in the amount of 2.5-5.0% of tablet weight. The new dosage form of azithromycin contains the high absolute (1000 mg) and relative (88.2%) concentration of the active substance that enables reaching the immediate therapeutic effect.
EFFECT: therapeutic preparation is storage-stable and complies with the Pharmacopoeia requirements.
| Title | Year | Author | Number |
|---|---|---|---|
| FORMULATION AND METHOD FOR PREPARING SOLID DOSAGE FORM OF THIOCTIC ACID | 2011 |
|
RU2448699C1 |
| PHARMACEUTICAL PREPARATION OF MOXIFLOXACIN | 2011 |
|
RU2466718C1 |
| METHOD OF TREATMENT OF PATIENTS WITH BACTERIAL INFECTION | 1995 |
|
RU2128998C1 |
| TWO-LAYERED TABLET FOR PREVENTING CARDIOVASCULAR DISTURBANCES, DRUG AND METHOD FOR PREVENTING CARDIOVASCULAR DISTURBANCES, INCLUDING APOPLEXY AND PARALYSIS BY USING SAID TABLET | 2007 |
|
RU2445088C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING HIV INFECTION, METHOD FOR PREPARING IT, AND METHOD OF TREATING | 2012 |
|
RU2505286C1 |
| PHARMACEUTICAL COMPOSITION OF MOXIFLOXACIN AND METHOD FOR PRODUCING IT | 2014 |
|
RU2558932C1 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING FENOSANIC ACID | 2019 |
|
RU2731536C1 |
| MODIFIED RELEASE DOSAGE FORM OF TRIMETAZIDINE DIHYDROCHLORIDE | 2009 |
|
RU2412706C1 |
| LAXATIVE SOLID DOSAGE FORM AND METHOD FOR PREPARING THEREOF (VERSIONS) | 2009 |
|
RU2401106C1 |
| ENCAPSULATED DOSAGE FORM, CONTAINING MONTELUKAST AND LEVOCETIRIZINE | 2012 |
|
RU2606857C2 |
